Study on heart attack patients with antiplatelet and colchicine therapy
Treatments studied
Part of Heart & circulation clinical trials.
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack with positive troponin (a protein in your blood that shows heart damage).
- You received an Orsiro stent (a small tube placed in your heart artery).
- You are at least 19 years old.
- You are not currently taking certain medications like strong antibiotics, antifungals, or other drugs that can interact (e.g., clarithromycin, cyclosporine).
- You do not have bone marrow problems, low blood cell counts, or severe stomach issues.
- You are not allergic to colchicine and do not already take it.
- You are not on blood thinners (anticoagulants).
- You do not have advanced liver or kidney disease.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have cancer now or in the last 5 years, and your life expectancy is over 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests whether colchicine (a medicine commonly used for inflammation) can improve how well clogged heart arteries reopen after a short-term heart emergency called ACS. You may be eligible if you’re hospitalized with ACS and are planned for a coronary angiogram and possible angioplasty soon.
This trial tests if colchicine, an anti-inflammatory medicine, can help people who recently had a heart attack. It looks for markers in your blood to see who might benefit most.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
This study tests if colchicine, a medicine used for gout and inflammation, can help people with coronary heart disease who have had a stent placed. You might be eligible if you have ongoing inflammation (measured by a simple blood test) and are already on standard heart medications.
This trial tests whether adding a targeted anti-inflammatory drug to standard care can prevent future heart attacks or strokes in people with high-risk chronic coronary artery disease. It is for people who have a moderate narrowing in a heart artery with a vulnerable plaque and signs of inflammation.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.